FDA Grants De Novo Marketing Authorization to Apollo Endosurgery for Apollo ESG and Apollo REVISE, New Endoscopic Systems for Patients with Obesity
Systems Offer Effective, Minimally Invasive Treatment Options for Millions of Patients with Obesity (BMI 30-50 kg/m2) Apollo Endosurgery, Inc. (Apollo) (NASDAQ:APEN), a global leader in minimally invasive medical devices for…